Panel to Feature Discussion About Creating a Winning Culture in the
Biotech Industry
TORONTO–(BUSINESS WIRE)–#FSDDF–FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the
“Company”), announced today that Executive Co-Chairman and Chief
Executive Officer, Dr. Raza Bokhari, will be featured in the 2019 BIO
International Convention’s panel presentation, “Building a Winning Team
for Biotech Business Success – Lessons You Can Learn from Industry
Veterans and Former NFL Player Turned Broadcaster Solomon Wilcots,” on
June 4 in Philadelphia, PA.
Moderated by Mr. Wilcots, the panel will feature an interactive
discussion on how industry leaders in biotech create a culture committed
to winning and why these approaches are applicable to fast-growing,
emerging biotech companies today. Joining Dr. Bokhari will be Mei Mei
Hu, CEO of United Neuroscience; Bill Newell, CEO of Sutro BioPharma; and
Gil Van Bokkelen, Chairman and CEO of Athersys.
Details of the panel are as follows:
| Panel: |
Building a Winning Team for Biotech Business Success – Lessons You Can Learn from Industry Veterans and Former NFL Player Turned Broadcaster Solomon Wilcots |
|
| Date: | Tuesday, Jun 4, 2019 | |
| Time: | 3:15 p.m. ET | |
| Location: | 107AB, Level 100, Pennsylvania Convention Center, Philadelphia, PA |
About FSD Pharma
FSD Pharma is focused on the development of the highest quality indoor
grown, pharmaceutical grade cannabis and on the research and development
of novel cannabinoid-based treatments for several central nervous system
disorders, including chronic pain, fibromyalgia and irritable bowel
syndrome. The Company has 25,000 square feet that is licensed at its
Ontario facility and expansion is currently underway.
FSD facilities sit on 70 acres of land with 40 acres primed for
development and an expansion capability of up to 3,896,000 square feet
by 2025.
FSD’s wholly-owned subsidiary, FV Pharma, is a licensed producer under
the Cannabis Act and Regulations, having received its cultivation
license on October 13, 2017 and its Sale for Medical Purposes license on
April 18, 2019. FV Pharma’s vision is to transform its current
headquarters in a Kraft plant in Cobourg, Ontario into the largest
hydroponic indoor grow facility in the world. FV Pharma intends to cover
all aspects of this exciting new industry, including cultivation, legal,
processing, manufacturing, extracts and research and development. For
additional information on the company, please visit our website at www.fsdpharma.com.
Forward-Looking Information
Neither the Canadian Securities Exchange nor its regulation services
provider accept responsibility for the adequacy or accuracy of this
release.
Certain statements contained in this press release constitute
forward-looking information. These statements relate to future
events or future performance. The use of any of the words “could”,
“intend”, “expect”, “believe”, “will”, “projected”, “estimated” and
similar expressions and statements relating to matters that are not
historical facts are intended to identify forward-looking information
and are based on FSD Pharma’s current belief or assumptions as to the
outcome and timing of such future events. Actual future results may
differ materially. Actual results and developments may differ materially
from those contemplated by these. The forward-looking information
contained in this press release is made as of the date hereof, and FSD
Pharma is not obligated to update or revise any forward-looking
information, whether as a result of new information, future events or
otherwise, except as required by applicable securities laws. Because of
the risks, uncertainties and assumptions contained herein, investors
should not place undue reliance on forward looking-information. The
foregoing statements expressly qualify any forward-looking information
contained herein.
Contacts
Investor Relations
Email: IR@fsdpharma.com
Website:
www.fsdpharma.com
Media Relations
Ned Berkowitz
Email: Ned.Berkowitz@russopartnersllc.com
Tel:
(646) 942-5629
Zeeshan Saeed, President and Founder, FSD Pharma Inc.
Email: zeeshan@fsdpharma.com
Telephone:
(416) 854-8884